KORRO BIO INC. - COMMON STOCK

27,05

21-февраля-25 12:51:11

15 мин. задержка

Акции

-1,60

-5,58%

Сегодняшний диапазон

26,79 - 29,27

ISIN

N/A

Источник

NASDAQ

Korro to Present at the TD Cowen 44th Annual Health Care Conference

27 фев 2024 07:00:01 Источник Nasdaq GlobeNewswire
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio

18 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference

04 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

07 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.